| Particulars |
| Company Name |
Cohance Lifesciences Ltd |
| Face Value |
1 |
| BSE Code |
543064 |
| Year End |
202503 |
| Full Year |
| Equity (Rs . Cr) |
38.26 |
| B.V. (Rs) |
60.90 |
| Sales (Rs . Cr) |
1,093.51 |
| NP (Rs . Cr) |
271.77 |
| NP Var% |
-8.00 |
| Div% |
0.00 |
| CPS (Rs) |
8.60 |
| EPS (Rs) |
7.10 |
| Traded Value(Rs . Lakhs) |
58.18 |
| 52 Week High |
1,359.00 |
| 52 Week Low |
857.00 |
| Price BSE |
877.00 |
| Price NSE |
876.00 |
| Market Capital(Rs . Cr) |
33,560.70 |
| P/C Ratio |
102.00 |
| P/E Ratio |
123.50 |
| Price Vs.BV |
14.40 |
| Latest Quarter |
| Year End |
202506 |
| Sales (Rs . Cr) |
483.58 |
| NP (Rs . Cr) |
58.56 |
| NP Var % |
-22.00 |
| Trailing Twelve Months |
| Year End |
202506 |
| Sales |
914.50 |
| OPM |
38.18 |
| NP |
247.20 |
| NP Var% |
38.03 |
| EPS |
9.23 |
| PE |
95.04 |
|